ClearPoint Neuro, Inc. (CLPT)

Market Cap	162.00M
Revenue (ttm)	22.32M
Net Income (ttm)	-21.86M
Shares Out	24.62M
EPS (ttm)	-0.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,842
Open	6.51
Previous Close	6.58
Day's Range	6.36 - 6.60
52-Week Range	4.05 - 11.00
Beta	1.19
Analysts	Strong Buy
Price Target	12.33 (+87.1%)
Earnings Date	Nov 9, 2023

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB, Konin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 108
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT

Financial Performance

In 2022, CLPT's revenue was $20.55 million, an increase of 26.09% compared to the previous year's $16.30 million. Losses were -$16.44 million, 14.1% more than in 2021.

Analyst Forecast

According to 3 analysts, the average rating for CLPT stock is "Strong Buy." The 12-month stock price forecast is $12.33, which is an increase of 87.10% from the latest price.

Price Target

$12.33

(87.10% upside)

Analyst Consensus: Strong Buy